Guest guest Posted October 17, 2003 Report Share Posted October 17, 2003 Thu, 16 Oct 2003 20:56:44 -0500 HSI - Jenny Thompson Sweet Heart Sweet Heart Health Sciences Institute e-Alert October 16, 2003 ************************************************************** Dear Reader, Imagine a medical condition that opens the door to a wide range of chronic health problems, leaving you vulnerable to cancer, heart disease, high blood pressure, stroke, and kidney failure. The condition is type 2 diabetes, and it currently claims about 16 million Americans. That's the combined populations of Colorado, Oklahoma, Oregon, and Connecticut. Unfortunately, too many doctors respond to patients diagnosed with type 2 diabetes the only way they know how: they medicate. As a result, as many as six million type 2 diabetics are taking drugs called thiazolidinediones (TZDs) that improve insulin sensitivity. Now a new study shows that this class of drugs may sharply increase the risk of pulmonary edema and congestive heart failure. Fortunately, most of those six million may be able to successfully address their diabetes without using any drugs at all. ----------------------------- Cardio stress ----------------------------- Investigating the relationship between TZDs and the development of pulmonary edema (PE) and congestive heart failure (CHF), researchers at the University of Texas Southwestern Medical Center examined the medical records of six diabetes patients admitted to the hospital suffering from symptoms of PE and CHF. Five of the subjects had been treated with TZD drugs pioglitazone or rosiglitazone. In all five cases, the threat of heart failure subsided quickly after the discontinuation of the TZD treatment, which had no permanent effect on cardiac function. Based on this small but conclusive trial, the authors of the study state that " thiazolidinediones can cause pulmonary edema or exacerbate heart failure. " They also state that TZDs should be avoided by patients with kidney disease or left ventricular dysfunction of the heart. Obviously, further examination of the relationship between TZDs and heart failure is called for. Until then, this is a study that every one of those six million pioglitazone and rosiglitazone users needs to be aware of. ----------------------------- Behavior modified ----------------------------- Most cases of type 2 diabetes are the result of poor diet and insufficient exercising habits that catch up with us as we age. Fortunately, the insulin resistance that triggers type 2 diabetes can often be reversed by modifying the diet and beginning a regular exercise program. In the e-Alert " Common Sense Approach To Treating Type II Diabetes " (2/13/02), I told you about a New England Journal of Medicine study involving more than 3,200 adults (average age was 51) who were diagnosed with pre-diabetic elevated glucose levels. Subjects were divided into three groups: one group received a daily dose of Glucophage (the brand name of metformin); one group received a daily placebo; and one group participated in an intensive program with a goal of at least 7 percent weight loss through diet adjustment, two and a half hours of moderate exercise each week, and educational sessions to reinforce behavior modification. After following these subjects for an average of almost 3 years, the researchers found that Glucophage reduced the incidence of diabetes by about 30 percent versus placebo, but lifestyle changes slashed the incidence rate by more than HALF - a full 58 percent. Plus, patients in the Glucophage group had six times more gastrointestinal side effects than those in the exercise and diet group. ----------------------------- More to come ----------------------------- Because type 2 diabetes increases the risk of so many health problems, the last thing a diabetic needs are the potential side effects that come with the use of any synthetic drug. In an upcoming e-Alert I'll tell you about a natural botanical and two vitamin supplements that have been shown to help type 2 diabetics regulate their blood sugar levels and protect the health of their kidneys. But it's clear from everything we know that changes in diet and exercise are the best medicine for most type 2 diabetics. ************************************************************** To start receiving your own copy of the HSI e-Alert, visit: http://www.hsibaltimore.com/ealert/freecopy.html Or forward this e-mail to a friend so they can sign-up to receive their own copy of the HSI e-Alert. ************************************************************** ... and another thing Here's some sage advice. In the e-Alert " Pain Takes a Holiday " (9/8/03) I told you how the herb sage has been shown to inhibit an enzyme called acetylcholinesterase (AChE), which breaks down a chemical called acetylcholine that is typically deficient in Alzheimer's patients. Now, a new study from the U.K. has confirmed that four compounds isolated from the extract of Chinese sage root act as AChE inhibitors. For more than a millennium, Chinese sage has been used to " prolong active life. " Professor Peter Houghton, one of the authors of the King's College London study, told NutraIngredients.com that, " Our data provide some justification for this traditional use. " Houghton's team is currently attempting to isolate the compounds in several Korean herbs, which have also been shown to inhibit AChE. Chinese sage - also known as danshen, salvia chinensis, and shi jian chuan - is available through many sources on the Internet, and can probably be found in most herbal shops. It rarely causes adverse side effects, which makes it preferable to Alzheimer's drugs such as donepezil; an AChE inhibitor with unpleasant side effects such as dizziness, weakness, and joint pain. If you've ever used a Chinese sage root extract to treat any type of memory or dementia problems, please drop us a line and tell us about your experience with it. To Your Good Health... and, oh, yeah... Go Ravens! Jenny Thompson Health Sciences Institute ************************************************************** Sources: " Thiazolidinedione-Associated Congestive Heart Failure and Pulmonary Edema " Mayo Clinic Proceedings, September 2003, Vol. 78, Pg. 1088, mayo.edu " Do Thiazolidinediones Cause Congestive Heart Failure? " Mayo Clinic Proceedings, September 2003, Vol. 78, Pg. 1077, mayo.edu " Diabetes Drugs Can Cause Heart Failure " Dr. Joseph Mercola, 9/24/03, mercola.com " Two Commonly Prescribed Diabetes Drugs May Cause Heart Failure And Fluid Buildup " University of Texas Southwestern Medical Center at Dallas, 9/9/03, sciencedaily.com " Sage, Alternative Treatment to Alzheimer's Drug " NutraIngredients.com, 9/23/03, nutraingredients.com Copyright ©1997-2003 by www.hsibaltimore.com, L.L.C. The e-Alert may not be posted on commercial sites without written permission. ************************************************************** Before you hit reply to send us a question or request, please visit here http://www.hsibaltimore.com/ealert/questions.html ************************************************************** If you'd like to participate in the HSI Forum, search past e-Alerts and products or you're an HSI member and would like to search past articles, visit http://www.hsibaltimore.com ************************************************************** To learn more about HSI, call (203) 699-4416 or visit http://www.agora-inc.com/reports/HSI/WHSID618/home.cfm. ************************************************************** ******* To manage your e-mail subscription, use our web interface at: http://www.agoramail.net/Home.cfm?List=hsiweb To cancel or for any other subscription issues, write us at: Order Processing Center Attn: Customer Service P.O. Box 925 Frederick, MD 21705 NEW WEB MESSAGE BOARDS - JOIN HERE. Alternative Medicine Message Boards.Info http://alternative-medicine-message-boards.info The New with improved product search Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.